Our June note put a D on EON and said the danger was dilution through a $150m equity facility. Six weeks later the stock is at $0.4942, down 13.2% from the 9 June close of $0.569 and 40.4% from the April entry at $0.83. No further dilution has come. Our June note recorded 11% of realised dilution; since then the share count has not moved. Shares outstanding are 49,968,344, the same figure as in June. Short interest fell from 10.84% of float to 7.6%. And management bought: fifteen open-market purchases and no sales between 30 June and 26 November 2025, 1,107,188 shares for $412,287 at an average of $0.3724, every one below today's price. But a 10% holder was going the other way, and that matters more. We were right on direction and wrong on mechanism. The real problem is that nobody can check the accounts. EON has filed nothing with the SEC since 28 April. The FY2025 annual report was due 15 April and is 112 days late. No balance sheet has been filed for any date after 30 September 2025. NYSE Regulation has set the cure deadline at 15 October, 71 days out.
EON Resources is a small oil and gas producer operating the Grayburg-Jackson field in the Permian Basin of south-eastern New Mexico, acquired through a 2023 SPAC combination. The asset is a mature conventional waterflood in the San Andres formation rather than a shale play, so the economics turn on workover and recompletion of existing wellbores more than on new horizontal drilling.
In September 2025 the company announced a farmout with Virtus Oil & Gas under which Virtus funds initial horizontal wells with EON carried, and management has since described a multi-well programme running to 2030. None of that activity has been reported in an audited financial statement. The last filed accounts cover the quarter ended 30 September 2025 and the FY2025 annual report has not been filed, so every operating figure published since is management assertion.
| Metric | Value | Signal |
|---|---|---|
| Price (4 Aug close) | $0.4942 | -13.2% since our 9 June note, -40.5% from the April entry at $0.83 |
| Market cap | $24.7M | 0.4942 x 49,968,344 shares |
| Book value / share | $1.352 | P/B 0.37x, unaudited since Sept 2025 |
| Revenue TTM | $17.31M | -16% year on year |
| EBITDA | -$2.83M | Negative before capex |
| Operating margin | -38.5% | Spends $1.39 per $1 of revenue |
| Profit margin | -12.2% | Loss-making |
| Return on equity | -4.96% | Eroding equity |
| Cash | $875,604 | As last reported, 30 Sept 2025 |
| Total debt | ~$40M (filed) | FIBT reserve-based loan $21.4M at 30 Jun 2025 + $15M seller note + ~$4M accrued |
| Enterprise value | ~$64M | $24.7M market cap + ~$40M filed debt - $0.9M cash |
| Beta | -1.43 | Moves against the market, typical of a distressed micro-cap |
| Analyst coverage | None | 0 upgrades, 0 downgrades, 0 initiations |
| RSI (14) | 44.5 |
| EMA 20 | $0.52 |
| EMA 50 | $0.55 |
| EMA 200 | $0.56 |
| MACD | -0.012 |
| ATR (14) | $0.04 |
Price sits below all three exponential averages and they are stacked bearishly: 20-day at $0.5177, 50-day at $0.5523, 200-day at $0.5614. MACD is -0.0121 against a signal line at -0.0085, so momentum is still deteriorating. RSI 44 is mid-range, not oversold. On the daily bars the working floor is $0.43, the low of 24 June and again of 2 July, held both times; the daily bars show further shelves beneath at $0.39 and $0.36, with the 52-week low at $0.267. Overhead, $0.62 is the first real resistance, touched twice and last on 23 July, then $0.74 and $0.83. Daily ATR is $0.0408 against a $0.0642 gap down to $0.43, so a single average session covers roughly 64% of that distance. Support is one bad day away, not one bad week. Correction to our previous version: it published resistances at $4.00 and $3.30 on a sub-dollar stock. That was a scale error carried from a stale source and it is fixed here against daily bars.
The dominant risk is no longer dilution, which has not occurred, but opacity. No audited or reviewed financial statement covers any period after 30 September 2025, the annual report is 112 days late, the company's own prior accounts have been declared unreliable, and the exchange has set a dated deadline of 15 October. Nobody can size a position against a balance sheet nobody has signed.
There is no position to take here, and the reason has changed since June. Then, the case against EON was imminent dilution through an equity facility. That did not happen: the share count has not moved in six weeks, the shorts have covered, and insiders were buying below today's price as recently as November. What replaced it is duller and harder to escape. The company cannot close its audit. No annual report for 2025, no quarterly report for either 2026 quarter, nothing filed since 28 April, and a listing deadline on 15 October. And it owes roughly $40m against $875,604 of cash. A 63% discount to book means nothing when the book is the unaudited number and the creditors rank ahead of it. Anyone still holding from the April entry at $0.83 is down 40.4%.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from real-time market data, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.